Join our CEO as he presents Cycuria Therapeutics‘ latest advancements in oncology innovation at the upcoming BIO-Europe conference in Vienna .
📍 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗩𝗶𝗲𝗻𝗻𝗮
🗓️ 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆, 𝗡𝗼𝘃 𝟱 | 𝟭𝟬:𝟯𝟬 𝗔𝗠 | Wow
Join our CEO as he presents the latest progress on CUR-101 development at the 2nd BioCentury Grand Rounds Europe conference, being held from September 23-25,
Prof Philipp Jost, along with other leading experts in the field, authored an invited commemorative review in Cell by Cell Press — titled “𝘾𝙚𝙡𝙡 𝘿𝙚𝙖𝙩𝙝
We are excited to share that our Founder, 𝗣𝗿𝗼𝗳. 𝗗𝗿. Philipp Jost, will be presenting at the 𝗔𝗔𝗖𝗥 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 in San Diego this
We’re proud to share that 𝗣𝗿𝗼𝗳. 𝗗𝗿. Philipp Jost , Scientific Founder of Cycuria Therapeutics , is featured in Drug Target Review discussing innovative strategies
At Cycuria, we are dedicated to developing novel cytokine-based therapies to dramatically improve outcomes for patients living with cancer, offering hope where traditional treatments have fallen short.